BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32623818)

  • 1. Anesthetic management of pediatric patients undergoing intrathecal nusinersen administration for treatment of spinal muscular atrophy: A single-center experience.
    Brollier LD; Matuszczak M; Marri T; Carbajal JG; Moorman AT; Sorial EM; Jain R
    Paediatr Anaesth; 2021 Feb; 31(2):160-166. PubMed ID: 32623818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective cohort study of children with spinal muscular atrophy type 2 receiving anesthesia for intrathecal administration of nusinersen.
    Bielsky AR; Fuhr PG; Parsons JA; Yaster M
    Paediatr Anaesth; 2018 Dec; 28(12):1105-1108. PubMed ID: 30284761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.
    Mousa MA; Aria DJ; Schaefer CM; Kaye RD; Abruzzo TA; Bernes SM; Willard SD; Riemann MC; Towbin RB
    Pediatr Radiol; 2018 Nov; 48(12):1797-1805. PubMed ID: 30022258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needleless inhaled anesthesia with sevoflurane: Advantages of a simplified approach for children with spinal muscular atrophy undergoing intrathecal administration of nusinersen.
    Salerno A; Picconi E; Genovese O; Piastra M; Pulitanò SM; Tosi F; Mancino A; Pane M; De Sanctis R; Carlini D; Mercuri EM; Conti G
    Paediatr Anaesth; 2023 Apr; 33(4):282-290. PubMed ID: 36636888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography-guided transforaminal lumbar puncture using local anesthesia and a straight 22-gauge spinal needle for intrathecal nusinersen in adults: Findings in 77 procedures.
    Cox M; Atsina KB; Ramchand P; Ji J; Sedora-Roman N; Pukenas B
    Interv Neuroradiol; 2022 Jun; 28(3):262-265. PubMed ID: 34424100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Combination of Neuraxial and Regional Anesthesia in a Child With Advanced Spinal Muscular Atrophy Type 1 Receiving Maintenance Nusinersen Therapy: A Case Report.
    Brown AF; Einhorn LM
    A A Pract; 2020 Apr; 14(6):e01206. PubMed ID: 32784322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nusinersen injections in adults and children with spinal muscular atrophy: a single-center experience.
    Özütemiz C; Karachunski P; Nascene DR
    Diagn Interv Radiol; 2020 Nov; 26(6):596-602. PubMed ID: 32436843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
    Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
    Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis.
    Flotats-Bastardas M; Linsler S; Zemlin M; Meyer S
    Pediatr Neurosurg; 2020; 55(1):54-57. PubMed ID: 31722365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedural sedation for paediatric patients with spinal muscular atrophy undergoing intrathecal treatment.
    Sever F; Özmert S; Arıbaş Öz N
    Br J Clin Pharmacol; 2023 Aug; 89(8):2465-2471. PubMed ID: 36932845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoliosis and spinal muscular atrophy in the new world of medical therapy: providing lumbar access for intrathecal treatment in patients previously treated or undergoing spinal instrumentation and fusion.
    Labianca L; Weinstein SL
    J Pediatr Orthop B; 2019 Jul; 28(4):393-396. PubMed ID: 30932967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
    Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
    J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: early results of technical success and safety.
    Weaver JJ; Natarajan N; Shaw DWW; Apkon SD; Koo KSH; Shivaram GM; Monroe EJ
    Pediatr Radiol; 2018 Mar; 48(3):392-397. PubMed ID: 29130140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis.
    Rosiak G; Lusakowska A; Milczarek K; Konecki D; Fraczek A; Rowinski O; Kostera-Pruszczyk A
    Neuroradiology; 2021 Apr; 63(4):539-545. PubMed ID: 33512541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1.
    Pechmann A; Langer T; Wider S; Kirschner J
    Eur J Paediatr Neurol; 2018 Jan; 22(1):122-127. PubMed ID: 29208343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen.
    Carrera-García L; Muchart J; Lazaro JJ; Expósito-Escudero J; Cuadras D; Medina J; Bosch de Basea M; Colomer J; Jimenez-Mallebrera C; Ortez C; Natera-de Benito D; Nascimento A
    Eur J Paediatr Neurol; 2021 Mar; 31():92-101. PubMed ID: 33711792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-guided cervical puncture for nusinersen administration in adolescents.
    Ortiz CB; Kukreja KU; Lotze TE; Chau A
    Pediatr Radiol; 2019 Jan; 49(1):136-140. PubMed ID: 30167764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.
    Pechmann A; Behrens M; Dörnbrack K; Tassoni A; Stein S; Vogt S; Zöller D; Bernert G; Hagenacker T; Schara-Schmidt U; Schwersenz I; Walter MC; Baumann M; Baumgartner M; Deschauer M; Eisenkölbl A; Flotats-Bastardas M; Hahn A; Horber V; Husain RA; Illsinger S; Johannsen J; Köhler C; Kölbel H; Müller M; von Moers A; Schlachter K; Schreiber G; Schwartz O; Smitka M; Steiner E; Stögmann E; Trollmann R; Vill K; Weiß C; Wiegand G; Ziegler A; Lochmüller H; Kirschner J;
    Brain; 2023 Feb; 146(2):668-677. PubMed ID: 35857854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforaminal intrathecal delivery of nusinersen for older children and adults with spinal muscular atrophy and complex spinal anatomy: an analysis of 200 consecutive injections.
    Weaver JJ; Hallam DK; Chick JFB; Vaidya S; Shin DS; Natarajan N; Rad N; Reis J; Koo KSH; Shivaram GM; Thibodeau A; Apkon S; Monroe EJ
    J Neurointerv Surg; 2021 Jan; 13(1):75-78. PubMed ID: 32471828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.